Proto Labs CFO Daniel Schumacher sells $476,604 in stock

Proto Labs CFO Daniel Schumacher recently sold 5,000 shares of the company's common stock, resulting in a total value of $476,604. The sales took place on September 24, 2026, with share prices fluctuating between $95.00 and $95.65 per share. The weighted average price for these transactions was $95.3209 per share. This sale occurred as Proto Labs' stock was trading close to its 52-week high of $96.92, having delivered a strong 91% return over the past year.

The transactions were carried out in accordance with a previously established Rule 10b5-1 trading plan adopted by Mr. Schumacher on June 5, 2026. Post-sale, Mr. Schumacher now holds a direct beneficial ownership of 35,019 shares of Proto Labs common stock. According to InvestingPro analysis, the company appears overvalued at present, trading at a P/E ratio of 76.4, implying that its shares are priced higher than many industry peers.

For those seeking deeper insights, InvestingPro offers 13 additional ProTips and a wealth of detailed financial metrics for PRLB via its research platform. Recently, Proto Labs reported robust second-quarter results, surpassing Wall Street's estimates with a record revenue of $149.3 million and adjusted earnings of $0.60 per share.

The company highlighted consistent growth across its manufacturing services, with its best quarter in three years. Moreover, Proto Labs has recorded three quarters of double-digit year-over-year growth and has raised its full-year revenue outlook. Needham recently upgraded Proto Labs' stock rating from Hold to Buy, setting a price target of $87.00, driven by the company's impressive growth momentum and operational enhancements under CEO Suresh Krishna.

These developments illustrate Proto Labs' resurgence, marking the firm's strongest growth in five years.